FR2113774B1 - - Google Patents

Info

Publication number
FR2113774B1
FR2113774B1 FR7040754A FR7040754A FR2113774B1 FR 2113774 B1 FR2113774 B1 FR 2113774B1 FR 7040754 A FR7040754 A FR 7040754A FR 7040754 A FR7040754 A FR 7040754A FR 2113774 B1 FR2113774 B1 FR 2113774B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7040754A
Other languages
French (fr)
Other versions
FR2113774A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROQUES ETS
Original Assignee
ROQUES ETS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROQUES ETS filed Critical ROQUES ETS
Priority to FR7040754A priority Critical patent/FR2113774A1/fr
Publication of FR2113774A1 publication Critical patent/FR2113774A1/fr
Application granted granted Critical
Publication of FR2113774B1 publication Critical patent/FR2113774B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7040754A 1970-11-13 1970-11-13 Prepn of l-ornithine salts with org acids - using silver oxides Granted FR2113774A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7040754A FR2113774A1 (en) 1970-11-13 1970-11-13 Prepn of l-ornithine salts with org acids - using silver oxides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7040754A FR2113774A1 (en) 1970-11-13 1970-11-13 Prepn of l-ornithine salts with org acids - using silver oxides

Publications (2)

Publication Number Publication Date
FR2113774A1 FR2113774A1 (en) 1972-06-30
FR2113774B1 true FR2113774B1 (enExample) 1974-03-22

Family

ID=9064117

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7040754A Granted FR2113774A1 (en) 1970-11-13 1970-11-13 Prepn of l-ornithine salts with org acids - using silver oxides

Country Status (1)

Country Link
FR (1) FR2113774A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945790C2 (de) * 1978-11-20 1987-03-12 Tanabe Seiyaku Co., Ltd., Osaka Neutrales L-Ornithin-L-malat-dihydrat und neutrales L-Lysin-L-malat-monohydrat und Verfahren zu deren Herstellung
FR2634374B1 (fr) * 1988-07-19 1993-10-15 Laboratoires Serobiologiques Agents photoprotecteurs, cytophotoprotecteurs cutanes ayant une activite photoprotectrice des cellules constitutives, fonctionnelles de la peau, en particulier des cellules de langerhans, a base de composes nucleiques : nucleoprotides, ribonucleotides et desoxyribonucleotides, ribonucleosides et desoxyribonucleosides, compositions cosmetiques ou dermo-pharmaceutiques contenant un tel agent ainsi que des nouveaux composes en soi
WO2006001378A1 (ja) * 2004-06-25 2006-01-05 Kyowa Hakko Kogyo Co., Ltd. Ｌ－オルニチン・クエン酸塩結晶
PL1824563T3 (pl) 2004-11-26 2010-07-30 Ucl Business Plc Kompozycje zawierające ornitynę i fenylooctan lub fenylomaślan do leczenia encefalopatii wątrobowej
SG174982A1 (en) 2009-04-03 2011-11-28 Ocera Therapeutics Inc L-ornithine phenyl acetate and methods of making thereof
JP5749255B2 (ja) 2009-06-08 2015-07-15 ユーシーエル ビジネス ピーエルシー Ｌ−オルニチンフェニル酢酸塩を用いる門脈圧亢進の治療及び肝機能の修復
IL281349B (en) 2014-11-24 2022-09-01 Ucl Business Ltd Treatment of diseases related to hepatic stellate cell activity using ammonia-lowering treatments
US10835506B2 (en) 2015-08-18 2020-11-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
CA3063134A1 (en) 2017-05-11 2018-11-15 Ocera Therapeutics, Inc. Processes of making l-ornithine phenylacetate

Also Published As

Publication number Publication date
FR2113774A1 (en) 1972-06-30

Similar Documents

Publication Publication Date Title
FR2113774B1 (enExample)
AU1473870A (enExample)
AU2044470A (enExample)
AU2130570A (enExample)
AU1326870A (enExample)
AU1336970A (enExample)
AU1517670A (enExample)
AU1716970A (enExample)
AU1833270A (enExample)
AU2017870A (enExample)
AU2085370A (enExample)
AU1832970A (enExample)
AU1918570A (enExample)
AU1328670A (enExample)
AU1343870A (enExample)
AU1581370A (enExample)
AU2144270A (enExample)
AU2131570A (enExample)
AU2130770A (enExample)
AU1591370A (enExample)
AU2119370A (enExample)
AU2115870A (enExample)
AU2112570A (enExample)
AU1603270A (enExample)
AU2061170A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse